Jay Tanna

Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT

Hannah Kinoshita, Kenneth R. Cooke, Melanie Grant et al. · Blood Advances · 2022 · 36 citations · Full text

Cell Therapy, Immunology, Cell Replacement Therapy +19

Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment

Michael D. Keller, Patrick J. Hanley, Yueh‐Yun Chi et al. · Nature Communications · 2024 · 21 citations · Full text

Critical testing and parameters for consideration when manufacturing and evaluating tumor–associated antigen-specific T cells

Jay Tanna, Robert Ulrey, Kirsten M. Williams et al. · Cytotherapy · 2019 · 13 citations

Tumor Immunology, Cancer Immunosurveillance, Medicine +12

The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy

Cynthia L. Gay, Patrick J. Hanley, Shane D. Falcinelli et al. · The Journal of Infectious Diseases · 2024 · 11 citations · Full text

Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children’s Oncology Group study

Birte Wistinghausen, Keri Toner, Donald A. Barkauskas et al. · Blood Advances · 2024 · 10 citations · Full text